AGP Picks
View all

The Global European
Provided by AGP

The Global European: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Global European.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 22, 2026

Progress Toward Production at Globex’s Bell Mountain Nevada Royalty Property
18 hours ago

Progress Toward Production at Globex’s Bell Mountain Nevada Royalty Property

Indeterminate GlobeNewswire
EnduroSat Names Spencer McCollester as SVP of Operations, US
18 hours ago

EnduroSat Names Spencer McCollester as SVP of Operations, US

Indeterminate GlobeNewswire
Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise
18 hours ago

Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise

Indeterminate GlobeNewswire
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
18 hours ago

AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series

Indeterminate GlobeNewswire
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion
18 hours ago

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion

Indeterminate GlobeNewswire
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
Jun. 22, 2026

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Indeterminate GlobeNewswire
Thousands to rally in Strasbourg to demand action over Turkey’s failure to enforce ECtHR rulings
Jun. 22, 2026

Thousands to rally in Strasbourg to demand action over Turkey’s failure to enforce ECtHR rulings

Indeterminate EIN Presswire
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
Jun. 22, 2026

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Indeterminate GlobeNewswire
NordLayer Named a Winner in the Expert Insights Cybersecurity Awards Summer 2026 for Network Security
Jun. 22, 2026

NordLayer Named a Winner in the Expert Insights Cybersecurity Awards Summer 2026 for Network Security

Indeterminate GlobeNewswire
ASML reports transactions under its current share buyback program
Jun. 22, 2026

ASML reports transactions under its current share buyback program

Indeterminate GlobeNewswire
Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition
Jun. 22, 2026

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition

Indeterminate GlobeNewswire
Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.
Jun. 22, 2026

Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.

Indeterminate GlobeNewswire
Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
Jun. 22, 2026

Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum

Indeterminate GlobeNewswire
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants
Jun. 22, 2026

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants

Indeterminate GlobeNewswire
Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis
Jun. 22, 2026

Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis

Indeterminate GlobeNewswire
Rezolve Ai Powers New Mashreq and Visa Everyday Cashback Program, Bringing AI-Enabled Card Linked Offers to UAE Cardholders
Jun. 22, 2026

Rezolve Ai Powers New Mashreq and Visa Everyday Cashback Program, Bringing AI-Enabled Card Linked Offers to UAE Cardholders

Indeterminate GlobeNewswire
Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers
Jun. 22, 2026

Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers

Indeterminate GlobeNewswire
Quantum Cyber Issues Letter to Shareholders
Jun. 22, 2026

Quantum Cyber Issues Letter to Shareholders

Indeterminate GlobeNewswire
BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026
Jun. 22, 2026

BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026

Indeterminate GlobeNewswire
DEEP SEA MINERALS CORP. WELCOMES G7 LEADERS’ DECLARATION ON SECURING CRITICAL MINERALS SUPPLY CHAINS
Jun. 22, 2026

DEEP SEA MINERALS CORP. WELCOMES G7 LEADERS’ DECLARATION ON SECURING CRITICAL MINERALS SUPPLY CHAINS

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Global European

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.